Overview
Rythm Health runs at-home blood testing by sending customers a painless self-collection kit, which they mail back to a centralized, clinical-grade laboratory. The lab performs validated assays with reference-method checks and delivers results within 48 hours, flagging any critical or abnormal values for provider consultation. The company controls every step from kit to result to ensure accuracy and consistency. Compared with traditional clinics and other direct-to-consumer testers, it emphasizes owning the entire process, broad accessibility, and straightforward pricing, including a single test option or a monthly subscription that is cancellable. The goal is to make reliable blood testing affordable and widely available without requiring a venous blood draw in a clinic.
Work here?Claim your company
Simplify's take
What believers are saying
- Rythm raised $31.1 million in June 2026, supporting growth and operations.
- November 2026 pages show 1-business-day shipping and two-day results, strengthening conversion.
- Trustpilot lists 4.8 stars and 3k-plus reviews, supporting brand credibility in crowded DTC testing.
What critics are saying
- June 2, 2026 terms force individual arbitration and mass-arbitration procedures against customers.
- A June 11, 2026 investigation targets hidden checkout fees, signaling consumer-protection exposure.
- If reimbursement stays absent, Rythm remains a discretionary wellness subscription vulnerable to churn.
What makes Rythm Health unique
- Rythm uses FDA-cleared Tasso+ collection and CLIA/CAP lab validation, unlike Theranos.
- Its November 2026 product page offers 25+ biomarkers, monthly testing, and AI coaching.
- The company controls collection, shipping, analysis, and results delivery nationwide across 50 states.
Help us improve and share your feedback! Did you find this helpful?